nach oben

Erschienen in:

08.11.2019 | Original Research

Roadblocks to PrEP: What Medical Records Reveal About Access to HIV Pre-exposure Prophylaxis

verfasst von: Avy A. Skolnik, PhD, Barbara G. Bokhour, PhD, Allen L. Gifford, MD, Brigid M. Wilson, PhD, Puja Van Epps, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Pre-exposure prophylaxis (PrEP) has been shown to be efficacious in preventing HIV; however, its uptake remains modest. Given that there are fewer cost barriers to receiving PrEP within VHA than via commercial insurance, VHA represents an ideal setting in which to study other barriers that may impact patients seeking PrEP.

Objective

We sought to understand potential barriers to obtaining PrEP within the Veterans Health Administration (VHA) through examination of documentation in electronic medical records.

Design

Retrospective structured chart review, including chart abstractions of notes, referrals, and communications; content analysis of charts from a subsample of patients receiving PrEP in VHA.

Participants

One hundred sixty-one patients prescribed PrEP at 90 sites varying in PrEP prescribing rates.

Approach

We extracted descriptive information and conducted a qualitative analysis of all PrEP-relevant free-text notes including who initiated the PrEP conversation (patient vs. provider), time interval between request and prescription, reasons for denying PrEP, and patient responses to barriers.

Key Results

Patients initiated 94% of PrEP conversations and 35% of patients experienced delays receiving PrEP ranging from six weeks to 16 months. Over 70% of cases evidenced barriers to access. Barriers included provider knowledge gaps about PrEP, provider knowledge gaps about VHA systems related to PrEP, confusion or disagreement over clinic purview for PrEP, and provider attitudes or stigma associated with patients seeking PrEP.

Conclusions

Although PrEP is recommended for HIV prevention in high-risk persons, many PrEP-eligible individuals faced barriers to obtaining a prescription. Current practices place substantial responsibility on patients to request and advocate for this service, in contrast to many other preventive services. Understanding the prevalence and content of PrEP knowledge gaps and attitudinal barriers can inform organizational interventions to increase PrEP access and decrease HIV transmission.

Pre-Exposure Prophylaxis (PrEP) | HIV Risk and Prevention | HIV/AIDS | CDC. https://www.cdc.gov/hiv/risk/prep/index.html. Published August 23, 2018. Accessed September 30, 2018.

Baeten JM, Donnell D, Ndase P, et al. Antiretroviral Prophylaxis for HIV-1 Prevention among Heterosexual Men and Women. N Engl J Med. 2012;367(5):399-410. https://doi.org/10.1056/NEJMoa1108524.CrossRefPubMedPubMedCentral

Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med. 2010;363(27):2587-2599. https://doi.org/10.1056/NEJMoa1011205.CrossRefPubMedPubMedCentral

Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973-1983. https://doi.org/10.1097/QAD.0000000000001145.CrossRefPubMedPubMedCentral

Kirby T, Thornber-Dunwell M. Uptake of PrEP for HIV slow among MSM. Lancet. 2014;383(9915):399-400. https://doi.org/10.1016/S0140-6736(14)60137-9.CrossRefPubMed

Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site. PLoS ONE. 2012;7(3):e33119. https://doi.org/10.1371/journal.pone.0033119.CrossRefPubMedPubMedCentral

Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820-829. https://doi.org/10.1016/S1473-3099(14)70847-3.CrossRefPubMedPubMedCentral

Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-Exposure Prophylaxis (PrEP) for HIV Infection: Results of a Survey of HIV Healthcare Providers Evaluating Their Knowledge, Attitudes, and Prescribing Practices. AIDS Patient Care STDs. 2013;27(10):553-559. https://doi.org/10.1089/apc.2013.0173.CrossRefPubMed

Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition — United States, 2015. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6446a4.htm. Accessed September 30, 2018.

10.

US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. Washington, DC: US Public Health Service; 2014.

11.

Maier MM, Gylys-Colwell I, Lowy E, et al. Health Care Facility Characteristics are Associated with Variation in Human Immunodeficiency Virus Pre-exposure Prophylaxis Initiation in Veteran’s Health Administration. AIDS Behav. 2018. https://doi.org/10.1007/s10461-018-2360-6.

12.

Garner W, Wilson BM, Beste L, Maier M, Ohl ME, Van Epps P. Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration. Am J Public Health. 2018;108(S4):S305-S310. https://doi.org/10.2105/AJPH.2018.304788.CrossRefPubMedPubMedCentral

13.

Sun CJ, Anderson KM, Bangsberg D, et al. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults’ Perspectives. J Gen Intern Med. 2019;34(4):535-543. https://doi.org/10.1007/s11606-019-04850-w.CrossRefPubMed

14.

Adams LM, Balderson BH. HIV Providers’ Likelihood to Prescribe Pre-exposure Prophylaxis (PrEP) for HIV Prevention Differs By Patient Type: A Short Report. AIDS Care. 2016;28(9):1154-1158. https://doi.org/10.1080/09540121.2016.1153595.CrossRefPubMedPubMedCentral

15.

Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV Providers’ Perceived Barriers and Facilitators to Implementing Pre-Exposure Prophylaxis in Care Settings: A Qualitative Study. AIDS Behav. 2014;18(9):1712-1721. https://doi.org/10.1007/s10461-014-0839-3.CrossRefPubMedPubMedCentral

16.

Blumenthal J, Jain S, Krakower D, et al. Knowledge is Power! Increased Provider Knowledge Scores regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. AIDS Behav. 2015;19(5):802-810. https://doi.org/10.1007/s10461-015-0996-z.CrossRefPubMedPubMedCentral

17.

Silapaswan A, Krakower D, Mayer KH. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. J Gen Intern Med. 2017;32(2):192-198. https://doi.org/10.1007/s11606-016-3899-4.CrossRefPubMed

18.

Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis. 2013;13(1):217. https://doi.org/10.1186/1471-2334-13-217.CrossRefPubMedPubMedCentral

19.

Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Admin Pol Ment Health. 2015;42(5):533-544. https://doi.org/10.1007/s10488-013-0528-y.CrossRef

20.

Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28(12):850-857.e9. https://doi.org/10.1016/j.annepidem.2018.05.003.CrossRefPubMed

21.

Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841-849. https://doi.org/10.1016/j.annepidem.2018.06.005.CrossRefPubMedPubMedCentral

22.

Hsieh H-F, Shannon SE. Three Approaches to Qualitative Content Analysis. Qual Health Res. 2005;15(9):1277-1288. https://doi.org/10.1177/1049732305276687.CrossRefPubMed

23.

Eaton LA, Driffin DD, Bauermeister J, Smith H, Conway-Washington C. Minimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-Negative, Black Men Who Have Sex with Men. AIDS Patient Care STDs. 2015;29(8):423-430. https://doi.org/10.1089/apc.2014.0303.CrossRefPubMedPubMedCentral

24.

Turner L, Roepke A, Wardell E, Teitelman AM. Do You PrEP? A Review of Primary Care Provider Knowledge of PrEP and Attitudes on Prescribing PrEP. J Assoc Nurses AIDS Care. 2018;29(1):83-92. https://doi.org/10.1016/j.jana.2017.11.002.CrossRefPubMed

25.

Fix GM, Hyde JK, Bolton RE, et al. The moral discourse of HIV providers within their organizational context: An ethnographic case study. Patient Educ Couns. 2018. https://doi.org/10.1016/j.pec.2018.08.018.

26.

Karasz A. The Visit Before the Morning After: Barriers to Preprescribing Emergency Contraception. Ann Fam Med. 2004;2(4):345-350. https://doi.org/10.1370/afm.105.CrossRefPubMedPubMedCentral

27.

Wallace JL, Wu J, Weinstein J, Gorenflo DW, Fetters MD. Emergency contraception: knowledge and attitudes of family medicine providers. Fam Med. 2004;36(6):417-422.PubMed

28.

Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH. Suboptimal awareness and comprehension of published pre-exposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2014;26(6):684-693. https://doi.org/10.1080/09540121.2013.845289.CrossRefPubMed

29.

Wimberly YH, Hogben M, Moore-Ruffin J, Moore SE, Fry-Johnson Y. Sexual history-taking among primary care physicians. J Natl Med Assoc. 2006;98(12):1924-1929.PubMedPubMedCentral

30.

Calabrese SK, Earnshaw VA, Underhill K, Hansen NB, Dovidio JF. The Impact of Patient Race on Clinical Decisions Related to Prescribing HIV Pre-Exposure Prophylaxis (PrEP): Assumptions About Sexual Risk Compensation and Implications for Access. AIDS Behav. 2014;18(2):226-240. https://doi.org/10.1007/s10461-013-0675-x.CrossRefPubMedPubMedCentral

31.

Sabin JA, Riskind RG, Nosek BA. Health Care Providers’ Implicit and Explicit Attitudes Toward Lesbian Women and Gay Men. Am J Public Health. 2015;105(9):1831-1841. https://doi.org/10.2105/AJPH.2015.302631.CrossRefPubMedPubMedCentral

Titel: Roadblocks to PrEP: What Medical Records Reveal About Access to HIV Pre-exposure Prophylaxis
verfasst von: Avy A. Skolnik, PhD
Barbara G. Bokhour, PhD
Allen L. Gifford, MD
Brigid M. Wilson, PhD
Puja Van Epps, MD
Publikationsdatum: 08.11.2019
Verlag: Springer US
Erschienen in: Journal of General Internal Medicine / Ausgabe 3/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05475-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Objective

Design

Participants

Approach

Key Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Disparities in Quality of Primary Care by Resident and Staff Physicians—Reply

A Comparison of AGREE and RIGHT: which Clinical Practice Guideline Reporting Checklist Should Be Followed by Guideline Developers?

Surgical Management of Lumbar Radiculopathy: a Systematic Review

Calling on Primary Care to Prevent BRCA-Related Cancers

Use of Z-Codes to Record Social Determinants of Health Among Fee-for-service Medicare Beneficiaries in 2017